These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 11526977)
21. Synergistic interaction between mazindol, an anorectic drug, and swim-stress on analgesic responses in the formalin test in mice. Vendruscolo LF; Takahashi RN Neurosci Lett; 2004 Jan; 355(1-2):13-6. PubMed ID: 14729223 [TBL] [Abstract][Full Text] [Related]
22. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine. Calcagnetti DJ; Holtzman SG Pharmacol Biochem Behav; 1991 Jan; 38(1):185-90. PubMed ID: 2017444 [TBL] [Abstract][Full Text] [Related]
23. Inflammation enhances peripheral mu-opioid receptor-mediated analgesia, but not mu-opioid receptor transcription in dorsal root ganglia. Schäfer M; Imai Y; Uhl GR; Stein C Eur J Pharmacol; 1995 Jun; 279(2-3):165-9. PubMed ID: 7556397 [TBL] [Abstract][Full Text] [Related]
24. Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A. Drinovac V; Bach-Rojecky L; Matak I; Lacković Z Neuropharmacology; 2013 Jul; 70():331-7. PubMed ID: 23499661 [TBL] [Abstract][Full Text] [Related]
25. [Analgesic effect of corticotropin-releasing factor administered into midbrain periaqueductal grey matter]. Iarushkina NI; Bagaeva TR; Filaretova LP Ross Fiziol Zh Im I M Sechenova; 2011 Dec; 97(12):1327-35. PubMed ID: 22384673 [TBL] [Abstract][Full Text] [Related]
26. Effects of dopaminergic agents on visceral pain measured by the mouse writhing test. Frussa-Filho R; Rocha JB; Conceição IM; Mello CF; Pereira ME Arch Int Pharmacodyn Ther; 1996; 331(1):74-93. PubMed ID: 8896712 [TBL] [Abstract][Full Text] [Related]
27. Differential effects of nomifensine and imipramine on motivated behavior in the runway model of intracranial self-stimulation. Esumi S; Kawaski Y; Nakamoto A; Sagara H; Gomita Y; Kitamura Y; Sendo T Eur J Pharmacol; 2013 Nov; 720(1-3):186-191. PubMed ID: 24436978 [TBL] [Abstract][Full Text] [Related]
28. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95). Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625 [TBL] [Abstract][Full Text] [Related]
29. Ethylketocyclazocine and bremazocine analgesia in neonatal rats. Helmstetter FJ; Calcagnetti DJ; Cramer CP; Fanselow MS Pharmacol Biochem Behav; 1988 Aug; 30(4):817-21. PubMed ID: 3067243 [TBL] [Abstract][Full Text] [Related]
30. Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex. Chindalore VL; Craven RA; Yu KP; Butera PG; Burns LH; Friedmann N J Pain; 2005 Jun; 6(6):392-9. PubMed ID: 15943961 [TBL] [Abstract][Full Text] [Related]
31. Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice. Reeta Kh; Mediratta PK; Rathi N; Jain H; Chugh C; Sharma KK Regul Pept; 2006 Jul; 135(1-2):85-90. PubMed ID: 16712978 [TBL] [Abstract][Full Text] [Related]
32. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833. Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650 [TBL] [Abstract][Full Text] [Related]
33. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay. Sterious SN; Walker EA J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605 [TBL] [Abstract][Full Text] [Related]